Global X Funds - Global X Price, Forecast, Insider, Ratings, Fundamentals & Signals

New york , jan. 19, 2024 /prnewswire/ -- global x etfs, the new york-based provider of exchange-traded funds, today announced the scheduled liquidation of the following etfs (the "funds"), based on an ongoing review process of its product lineup to ensure it meets the evolving needs of its clients. the funds scheduled for liquidation include: fund ticker cusip global x cannabis etf potx 37954y145 global x carbon credits strategy etf ntrl 37960a586 global x china biotech innovation etf chb 37954y251 global x green building etf grnr 37960a842 global x health & wellness etf bfit 37954y798 global x metaverse etf vr 37960a834 global x msci china communication services etf chic 37950e804 global x msci china consumer staples etf chis 37954y558 global x msci china energy etf chie 37950e507 global x msci china financials etf chix 37950e606 global x msci china health care etf chih 37954y541 global x msci china industrials etf chii 37950e705 global x msci china information technology etf chik 37954y533 global x msci china materials etf chim 37950e242 global x msci china real estate etf chir 37960a685 global x msci china utilities etf chiu 37954y517 global x msci next emerging & frontier etf emfm 37950e218 global x msci pakistan etf pak 37954y335 global x msci portugal etf pgal 37950e192   based upon the recommendation of global x management company llc, the global x funds' adviser, the board of trustees determined on january 19, 2024 that it was in the best interests of the funds and their shareholders to liquidate each of the funds.

The week ending in February 15 featured the Exchange conference in Miami, Florida, and launches were muted as a result. Only one new ETF made its debut during the week.

One of the top-performing thematic segments this year is cannabis. A major catalyst has been the proposed descheduling of it from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA).

Support for cannabis legalization reached all-time highs in 2023, creating a long list of cannabis stocks to buy. For one, a new Gallup survey found that 70% of Americans believe cannabis should be legal, which is a record high.

So far this month, Wall Street remained almost flat. But a few ETF areas have been hovering at around a month-high and have been still gaining strength.

Cannabis stocks will eventually see higher highs — with patience. Right now, we're waiting to see if the Drug Enforcement Administration (DEA) takes the U.S. Department of Health and Human Services' (HHS) advice to remove cannabis as a Schedule I drug, which could boost related stocks.

Cannabis stocks may be one of the most controversial trades on the market. But it could also turn out to be one of the most profitable.

Like any recovering reporter, I like to keep tabs on my old beats, and the marijuana ETF space never disappoints. Or, perhaps more accurately, it never stops disappointing.

Cannabis stocks are in focus after the Secure and Fair Enforcement Regulation Banking Act moved forward in the upper chamber of Congress on Wednesday. What the renegotiated SAFER means for cannabis companies The bill will enable financial institutions including banks to serve the state-legal marijuana companies without the risk of a federal crackdown.

Cannabis is now the sixth most valuable crop in the United States, with an estimated 2022 harvest value of $5 billion. Over the last 52 weeks, the Global X Cannabis ETF is down roughly 52%. The global cannabis sector is expected to grow from $28 billion in 2022 to $82 billion by 2027, leading to potential growth in the industry.

Investing and trading cannabis stocks has been extraordinarily difficult. I feel for those who took a bet for all the right reasons (which we'll get into).